RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
151 hedge funds and large institutions have $827M invested in Revance Therapeutics, Inc. in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 56 increasing their positions, 41 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
-7
Holders Change %
-4.43%
% of All Funds
2.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
34
Increased
56
Reduced
41
Closed
37
Calls
$11.7M
Puts
$9.78M
Net Calls
+$1.96M
Net Calls Change
+$5.27M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$113M |
| 2 |
HM
HealthCor Management
New York
|
$23.7M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
$71.3M |
| 4 |
Capital World Investors
Los Angeles,
California
|
$60.6M |
| 5 |
D.E. Shaw & Co
New York
|
$8.55M |
